AU4618696A - Uses of a vitamin of the k-group against a loss of cognitive faculties - Google Patents
Uses of a vitamin of the k-group against a loss of cognitive facultiesInfo
- Publication number
- AU4618696A AU4618696A AU46186/96A AU4618696A AU4618696A AU 4618696 A AU4618696 A AU 4618696A AU 46186/96 A AU46186/96 A AU 46186/96A AU 4618696 A AU4618696 A AU 4618696A AU 4618696 A AU4618696 A AU 4618696A
- Authority
- AU
- Australia
- Prior art keywords
- vitamin
- loss
- group against
- cognitive faculties
- faculties
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/82—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving vitamins or their receptors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/28—Neurological disorders
- G01N2800/2814—Dementia; Cognitive disorders
- G01N2800/2821—Alzheimer
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Cell Biology (AREA)
- Pathology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19504003A DE19504003A1 (en) | 1995-02-08 | 1995-02-08 | Treatment of cognitive disorders, esp. Alzheimer's disease |
DE9504003 | 1995-02-08 | ||
PCT/DE1996/000183 WO1996024345A2 (en) | 1995-02-08 | 1996-02-07 | Uses of a vitamin of the k-group against a loss of cognitive faculties |
Publications (1)
Publication Number | Publication Date |
---|---|
AU4618696A true AU4618696A (en) | 1996-08-27 |
Family
ID=7753374
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU46186/96A Abandoned AU4618696A (en) | 1995-02-08 | 1996-02-07 | Uses of a vitamin of the k-group against a loss of cognitive faculties |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP0759748A1 (en) |
AU (1) | AU4618696A (en) |
DE (1) | DE19549262C2 (en) |
WO (1) | WO1996024345A2 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008126367A1 (en) * | 2007-04-05 | 2008-10-23 | J-Oil Mills, Inc. | Ataractic agent and functional food |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4438208A (en) * | 1982-05-27 | 1984-03-20 | The Regents Of The University Of California | Region-specific determinants for vitamin K dependent bone protein |
DE3485711D1 (en) * | 1983-03-04 | 1992-06-17 | Scripps Clinic Res | IMMUNOADSORBENS AND METHOD FOR RECOVERING VITAMIN-K-DEPENDENT PROTEINS BY THIS ADSORBENT. |
US5037811A (en) * | 1990-04-17 | 1991-08-06 | Allergan, Inc. | 4-(oxygen, sulfur or nitrogen substituted)-methyl 5-hydroxy-2(5H)-furanones as anti-inflammatory agents |
AU620929B2 (en) * | 1988-10-27 | 1992-02-27 | Bar-Ilan University | Method and compositions for treating alzheimer's disease, related dementias and epilepsy |
US5262332A (en) * | 1989-04-05 | 1993-11-16 | Brigham And Women's Hospital | Diagnostic method for Alzheimer's disease: examination of non-neural tissue |
JPH08768B2 (en) * | 1989-08-24 | 1996-01-10 | 武田薬品工業株式会社 | Nerve growth factor secretion inducer |
US5668117A (en) * | 1991-02-22 | 1997-09-16 | Shapiro; Howard K. | Methods of treating neurological diseases and etiologically related symptomology using carbonyl trapping agents in combination with previously known medicaments |
FR2678638A1 (en) * | 1991-07-03 | 1993-01-08 | Inst Nat Sante Rech Med | Polyclonal and monoclonal antibodies against the tau protein for the diagnosis of Alzheimer's disease |
JPH06340526A (en) * | 1993-06-02 | 1994-12-13 | Mitsui Toatsu Chem Inc | Agent for inducing production and secretion of nerve growth factor containing substituted 1,4-naphthoquinone derivative as active component |
ES2136167T3 (en) * | 1993-06-18 | 1999-11-16 | Takeda Chemical Industries Ltd | IDEBENONE COMPOSITIONS TO TREAT ALZHEIMER'S DISEASE. |
-
1995
- 1995-02-08 DE DE19549262A patent/DE19549262C2/en not_active Expired - Fee Related
-
1996
- 1996-02-07 WO PCT/DE1996/000183 patent/WO1996024345A2/en not_active Application Discontinuation
- 1996-02-07 AU AU46186/96A patent/AU4618696A/en not_active Abandoned
- 1996-02-07 EP EP96901702A patent/EP0759748A1/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
EP0759748A1 (en) | 1997-03-05 |
WO1996024345A3 (en) | 1997-02-20 |
WO1996024345A2 (en) | 1996-08-15 |
DE19549262A1 (en) | 1996-09-05 |
DE19549262C2 (en) | 1997-10-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU1429397A (en) | Labeled vitamin d compounds and the use thereof | |
AU7186996A (en) | Blowoff orifice | |
AU7842294A (en) | Headset interface assembly | |
AU1277797A (en) | Kingpin assembly | |
AU7292396A (en) | Press-stud | |
AU3009395A (en) | Headband magnifier | |
AU1182497A (en) | Self-pierce rivet | |
AU4325396A (en) | Differential myometer | |
AU4329396A (en) | Use of 3,4-diphenylchromans | |
AU6667396A (en) | A novel use of soy molasses | |
AU4936396A (en) | Watchstrap clasp | |
AUPN088395A0 (en) | Structural member | |
AU7563194A (en) | Extreme pressure lubricant | |
AU4418096A (en) | Diagnosis of pancreatitis | |
AU5764194A (en) | Capsule | |
AU7427994A (en) | Recovery of carotenes | |
AU5990196A (en) | Multiple squib assembly | |
AU4891796A (en) | Mooring assembly | |
AU4361696A (en) | New uses of indolo-{2,3b}-quinoxalines | |
AU4988696A (en) | Antitussive microcapsules | |
AU4834593A (en) | Masking member | |
AU4618696A (en) | Uses of a vitamin of the k-group against a loss of cognitive faculties | |
AU7694996A (en) | Well fluid | |
AU5290496A (en) | Pressure converter (b) | |
AU8158694A (en) | Firestop assembly |